Sitemap - 2025 - Mendelspod
Petter Brodin of Karolinska: How Spatial Interactomics Could Transform Autoimmune Therapy
From GWAS to EWAS: Chirag Patel and and Gary Miller on the Rise of Exposomics
Agilent Partners with PacBio to Speed Adoption of Long Reads into Diagnostic Testing
How AI Is Doing Science with Vivek Adarsh, CEO of Mithrl
Inventor Mark Kokoris on Roche’s New Sequencing by Expansion
From Brewing Sake to Brewing Science: Takara Bio’s Bold New Chapter with CSO Andrew Farmer
How Pathologists Can Lead in Precision Medicine with David Braxton
From DNA to Proteins: Illumina Makes Its Proteomics Play - with Krishna Morampudi
Theranos Had the Vision. Truvian Has the Execution. Our Chat with CEO Jay Srinivasan
Physicians Don't Want a Laundry List of Genes says Premal Shah, CEO of Myome
The Customer Case for iconPCR with Stefan Green and Yann Jouvenot
Alex Dickinson on Long Read Sequencing, Multi Omics, and the Next Frontier in Genomics
Rapid Answers for Rare Disease: Katherine Stueland on GeneDx’s Mission
Moran Snir's Vision for Making Genomic Care Routine across the U.S.
How Certis Is Rewriting Cancer Models with CEO Peter Ellman
Myriad’s Next Chapter: New CEO Sam Raha on Growth, AI, and MRD Testing
Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz
Bodour Salhia and Danielle Goldberg: Rethinking Cancer Research with Illumina's 5-Base Solution
Reinventing PCR: Pranav Patel, N6 Tec
Remembering Atul Butte with Marina Sirota, Chirag Patel and Mike Snyder
The Age of Digital Pathology with Andy Beck, PathAI
From Illumina to Advocacy: Mike Kreitzinger on the Future of Clinical Genomics
Amplifying the Expert: Jing Gao on Illumina's Connected Insights
The End of Animal Testing? Vivodyne Scales Human Tissue with CEO Andrei Georgescu
How Liquid Biopsy Is Becoming Standard of Care with Rita Shaknovich, CMO, Agilent
Tracking GMOs in the Gene Editing Era: Frédéric Debode on the Science of GMO Detection
From Paris to the Pentagon: Sophie Peresson Maps Biosecurity’s New Landscape
From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision
The Grammar of RNA: Gavin Knott on Gene Editing and Structural Biology in the Age of AI
The Third Way: Christian Schafmeister’s Spiroligomer Revolution
Can Math and AI Replace Some Biology in Drug Discovery? with Aridni Shah, Immunito AI
$10 Genome, $8 Coffee: Rethinking the Economics of Life Science Tools with Stephane Budel, DeciBio
Quantum Scale: A New Era for Single-Cell Analysis with Giovanna Prout
Building Intuition at the Nanoscale: Steve McCloskey of Nanome on the VR Future of Science
Beyond the $100 Genome--the Everyday Sequencing Revolution You Missed: Mark Budde, Plasmidsaurus
What Next for LDTs? A Conversation with Sarah Overton of Velsera
AI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com
We've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude's
Aaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer Research
Toward Disease Sub-typing with Ben Busby, DNAnexus
Synthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John Cumbers
DNA Is Still Where It's At: Christian Henry, CEO of PacBio, on Watershed Year in 2024
Unlocking the Future of Forensic Genetics with Mirna Ghemrawi
Public Science in Peril: Hank Greely of Stanford on Funding, Fishing, and the Fight for Knowledge
Breaking the ‘Undruggable’ Barrier with AI and Synthetic Biology: Eswar Iyer, CEO of Aikium
The Rise of Quinn—iollo’s AI Scientist with CEO Daniel Gomari
Remembering Ayanna, our Executive Producer
Early Detection for Lung Cancer with Susan Tousi, DELFI Diagnostics
Big RNA with Brendan Frey of Deep Genomics
Genome Informatics in the Age of AI With Ben Busby, DNAnexus
AI & the Future of Genetic Testing: Ezra Cohen, CMO of Tempus